CTI Molecular Imaging posts double-digit revenue gain

CTI Molecular Imaging Inc. said that it has made "a good start" in its first fiscal quarter, ending Dec. 31, 2003, to balance long-term growth with its quarterly objective to meet and exceed earnings per share goals.

Net revenues rose 22 percent to $74.1 million, compared with $60.6 million in the first quarter of FY03. Net income slipped to $700,000, compared with $3.4 million in the year-ago quarter.

In the quarter, CTI shipped 26 scanners and booked orders for an additional 55 units. Twenty-one of those scanners shipped through CTI's partners and distributors, while 36 of its 55 orders came through those same channels. Those results compare with a total of 30 scanners shipped and 56 total orders taken in the year-ago quarter.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup